Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

UCB’s Bimzelx gains ground in the psoriasis arms race

Bimzelx’s latest win reshapes the psoriasis market

Nitish Kishor | 21 May 2026

Takeda Pharmaceutical Company Limited hit with $885m antitrust penalty in pay-for-delay case

A landmark verdict that rewrites the rules of pharma settlements

Vinay Lochav | 21 May 2026

Drug Discovery as a Machine Learning Problem: When Algorithms Make Pharmaceuticals Obsolete

Key HighlightsTraditional drug discovery takes 12 years and costs over $2 billion per approved drug, with a 90% clinical trial failure rate that AI is systematically addressing.AlphaFold solved the protein folding problem in structural biology, unlocking decades of compounding scientific progress that will fundamentally …

Nitish Kishor | 20 May 2026